2024年7月5日 · Here, we reformulate lipid nanoparticles (LNPs) through adjustments in lipid material structures and compositions to systematically achieve the pulmonary and hepatic (respectively) targeted mRNA...

2024年4月18日 · Unlike conventional four-component lipid nanoparticles (LNPs) that predominantly target the liver and possess complex constituents, we designed simplified one-component ionizable cationic lipid/mRNA nanoparticles (CLNs) for extrahepatic mRNA delivery.

Kexin SU | Cited by 11 | of Zhejiang University, Hangzhou (ZJU) | Read 3 publications | Contact Kexin SU

Su Kexin in the news. Models.com: MDX. Sep 6 2019. Confirmed S/S 2020 NYFW Feb 9 2019. CONFIRMED: F/W 19 NYFW Social Media; 876 Top ...

Here, we reformulate lipid nanoparticles (LNPs) through adjustments in lipid material structures and compositions to systematically achieve the pulmonary and hepatic (respectively) targeted mRNA distribution and expression.

ORCID record for Kexin Su. ORCID provides an identifier for individuals to use with their name as they engage in research, scholarship, and innovation activities.

0 Followers, 206 Following, 53 Posts - 蘇可欣 (@su__kexin) on Instagram: "試"

苏可欣于7月25日参于港姐候选佳丽比赛，30位港姐候选佳丽以优雅造型登场，大会当场公布20位佳丽晋级第二阶段比赛，苏可欣获选港姐20强之一 …… 苏可欣，2016香港小姐20强选手 。 苏可欣于7月25日参于港姐候选佳丽比赛，30位港姐候选佳丽以优雅造型登场，大会当场公布20位佳丽晋级第二阶段比赛，苏可欣获选港姐20强之一.

Kexin Su's 5 research works with 48 citations and 104 reads, including: Indolizine Synthesis via Radical Cyclization and Demethylation of Sulfoxonium Ylides and 2 (Pyridin-2-yl)acetate...

SU KEXIN｜HONEST（オネスト）株式会社のアーティストページです。 所属アーティストの詳細なプロフィールや最新情報についてご案内します。